Newton, MA, United States of America

Xuri Gao

USPTO Granted Patents = 40 

 

Average Co-Inventor Count = 6.6

ph-index = 10

Forward Citations = 210(Granted Patents)


Location History:

  • Watertown, MA (US) (2013)
  • Newton, MA (US) (2012 - 2021)
  • Newtonville, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
40 patents (USPTO):

Title: Xuri Gao: Innovations in Hepatitis B Antiviral Agents

Introduction:

In the world of healthcare, inventors and innovators such as Xuri Gao play a crucial role in developing groundbreaking solutions to combat diseases. Xuri Gao, hailing from Newton, MA (US), is recognized for his significant contributions in the field of hepatitis B antiviral agents. With an impressive tally of 34 patents to his name, Gao's work has garnered attention worldwide. Let's explore his latest patents, career highlights, and notable collaborations.

Latest Patents:

Gao's latest patents revolve around the development of hepatitis B antiviral agents. His significant contributions include compounds that inhibit the proteins encoded by the hepatitis B virus (HBV) or interfere with the HBV life cycle. These compounds, categorized under Formula (I), have demonstrated efficacy as potent antiviral agents. Additionally, Gao has also formulated pharmaceutical compositions utilizing these compounds for the treatment of HBV infection in affected individuals.

Career Highlights:

Xuri Gao's professional journey has been marked by his association with renowned companies in the pharmaceutical industry. Notable among them are Enanta Pharmaceuticals, Inc. and Novartis AG. Through his work with these esteemed organizations, Gao has demonstrated expertise in the development of innovative treatments for various diseases, with a focus on antiviral agents for hepatitis B.

Collaborations:

Collaboration has played an essential role in Gao's career, enabling him to enhance his research and bring novel treatments to the market. Two noteworthy collaborators are Yat Sun Or and Hui Cao, who have worked alongside Gao in exploring the development of hepatitis B antiviral agents. Their joint efforts have resulted in patents that have the potential to revolutionize the treatment of HBV infection.

Conclusion:

Xuri Gao's contributions to the field of hepatitis B antiviral agents have been truly remarkable. His dedication, expertise, and patents demonstrate his commitment to improving global healthcare outcomes, particularly in the fight against HBV infection. Gao's collaborations with esteemed companies and fellow researchers have further amplified the impact of his work. As we eagerly anticipate future innovations, it is evident that Xuri Gao will continue to be a driving force in the advancement of antiviral therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…